Characteristics | Values |
Sex, female/male, n | 7/4 |
Age, mean (SD), years | 73.3 (10.1) |
BMI, mean (SD), kg/m2 | 21.3 (2.5) |
Comorbid disease, n | |
Regular narcotic/sedative use | 0 |
Heart disease | 2 |
Lung disease | 1 |
Renal disease | 2 |
Liver disease | 2 |
Sleep apnoea | 1 |
AHA class (I, II) | 4, 7 |
Indication, n | |
Benign biliary stenosis | 1 |
Malignant biliary stenosis | 1 |
Choledocholithiasis | 4 |
Papillary tumour resection | 1 |
Chronic pancreatitis | 2 |
IPMN | 2 |
Baseline vital signs, mean (SD) | |
Oxygen saturation, % | 97.2 (2.4) |
Heart rate, beats per minute | 77 (7.9) |
Systolic blood pressure, mm Hg | 132 (19.2) |
Total drug dose, mean (range), mg | |
Flunitrazepam | 0.6 (0.2–1) |
Pethidine | 35 (35–70) |
Procedure time, mean (range), min | 41 (18–81) |
.AHA, American Heart Association;BMI, body mass index; IPMN, intraductal papillary mucinous neoplasm.